ABOUT US

BPTX, Inc.'s priority is improving overall health across the globe. Our mission is to protect business and home owners from existing and future bacterial/mold threats and provide them with a truly clean, healthy environment. 

ADDRESS

9595 Six Pines Drive, Suite 8210

The Woodlands, TX 77380

(936) 994-7016

(832) 408-7892 (fax)

info@protex90.com

QUICK SEARCH

PROTEX90 GETS RESULTS

"When the recommended methods, means, and procedures are followed as a matter of routine practice, these results can be achieved in all Protex-90 treated healthcare facilities."

-Paul J. Pearce PhD, Specialist in Microbiology,

American Society of Clinical Pathologists, Board of Certification

GOAL:

REDUCE BACTERIAL

CONTAMINANTS

Healthcare facilities regularly have outbreaks of Staphylococcus aureus, Escherichia coli, Enterococcus species, Klebsiella species, Proteus mirabilis, Pseudomonas aeruginosa, Coagulase negative Staphylococcus, Clostridia species, Candida albicans, Fungi/mold and other Gram negative bacteria, plus influenza and norovirus, affecting both patients and employees, which presents legal and financial issues for the hospital. Reducing bacterial contamination is a top priority. The current approach, cleaning with disinfectant alone, is ineffective.

Protex90 was designed to provide continued surface protection against newly introduced bacteria/viruses for a minimum of 90 days in high touch areas; presenting a long-term solution for reducing HAIs. That means if a patient sneezes​ on a surface (porous or non-porous) that was treated with Protex90 within the last 3-months, our solution would perform a mechanical kill on the bacteria cell upon contact; dramatically minimizing bacterial spread. 

SUMMARIZED STUDY RESULTS

Microscope

Pre Protex90 Treatment (3.13.18)- 68% of all samples taken had microorganisms detected, while 32% were found to be free of microorganisms.

Post Protex90 Treatment (5.14.18)- Of the previously positive areas, 87% were found to be free of microorganisms, meaning just 13% of previously positive testing areas continued to show the presence of microorganisms.

60 days post-application

Overall Findings

The doctors and nurses brainstorm power

Pre Protex90 Treatment (3.13.18)- High level of Bile Tolerant Gram Negative Bacilli detected. 

Post Protex90 Treatment (5.14.18)- 60 days after application there is no specified microorganisms detected. 

Exam Light Lamp

Sampling Site 1- ER, Room 19

Newborn sleeping in hospital crib.jpg

Pre Protex90 Treatment (3.13.18)- Bile Tolerant Gram Negative Bacilli and Fungi/Mold detected. 

Post Protex90 Treatment (5.14.18)- 60 days after application there is no specified microorganisms detected. 

Crib/Bed Sheets

Sampling Site 2- ER, Room 1

RESULTS INDICATE

81%

IMROVEMENT

STUDY METHODOLOGY

A third party study was requested by a premier hospital in the northeast. This study was done at their hospital.  Protex90 was tested in an active hospital environment by an independent microbiologist over the course of 8-weeks in 2018. The hospital wanted to see a quantifiable 15-20% reduction in bacterial contamination levels. They also requested that our applications cause minimal disruptions to the hospital. 

The testing was based on the microbiological evaluation of multiple sampling sites. BPTX and the independent microbiologist designated the study, under the dynamic contact conditions, be PASS/FAIL. This meant if any bacteria were found, it would be considered a failure. After the hospital cleaning crew completed a room, the microbiologist took his samples from random areas. After the samples were taken, Protex90 was applied to the sample areas; performed by BPTX's professional team. 60 days later the microbiologist returned to take new samples. 

Please note; the samples were only taken from sites that had failed the initial test. 

 

Protocol #1

Hospital SOP (Standard Operating Procedure) was not changed in any way.

Protocol #2

Protex90 was applied once at the very beginning of the 8-week independent study.

Protocol #3

Specific organisms were identified and correlated with the hospital antibiogram.

Protocol #4

Sample collection, processing and testing was conducted according to USP<61><62>, ISO11737, USEPA and USFDA guidelines.

APPLICATION PROCESS

Protex90 forms a long-lasting micro biostatic barrier on all treated surfaces (think tables, door knobs, walls, etc). To successfully cover all porous and non-porous surfaces, Protex90 is applied using a variety of foggers and electrostatic sprayers.

 

Each delivery method has specific advantages over one another, and are often utilized in conjunction with one another. Each team leader is trained on these advantages, and develops a unique application strategy for each customer.

KEY TAKEAWAYS

We saw a drastic reduction in bacterial contaminant. Taken 

60 days post-treatment, results show Protex90's surface barrier protection is 81% more effective than traditional disinfectant methods. 

The application process proved to be non-disruptive to the hospitals daily routine. The staff simply had to wait 10 minutes for Protex90 to dry before bringing a patient into the treated room.  

The treatment process was 100% safe for staff and patients.  

Protex90 is a non-toxic, water based solution that is safe for the environment and its occupants.